Who owns ACURX PHARMACEUTICALS INC COM NEW?

Tip: Access positions for across all investors

Analyze quarterly positions in Acurx Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Acurx Pharmaceuticals stock

Who bought or sold ACURX PHARMACEUTICALS INC COM NEW this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Vanguard Group 23k $58k 100% Dec 2025
 View chart
Prospect Financial Services 20k $49k 0% Dec 2025
 View chart
Northern Trust 17k $42k 100% Dec 2025
 View chart
Geode Capital Management 12k $31k 100% Dec 2025
 View chart
Jane Street 11k $27k 100% Dec 2025
 View chart
Tower Research Capital 2.9k $7.2k 168% Dec 2025
 View chart
Wells Fargo & Company 2.3k $5.7k 100% Dec 2025
 View chart
Nbc Securities 1.5k $3.7k 0% Dec 2025
 View chart
Group One Trading 283.00 $705.009600 -5% Dec 2025
 View chart
UBS Group 169.00 $338.000000 100% Dec 2025
 View chart
Cornerstone Planning Group 167.00 $432.997600 149% Dec 2025
 View chart
Advisor Group Holdings 100.00 $249.000000 -59% Dec 2025
 View chart
BlackRock 60.00 $148.998000 0% Dec 2025
 View chart
SBI Securities 13.00 $31.999500 0% Dec 2025
 View chart

Who sold out of Acurx Pharmaceuticals?

Fund or Company Name Date Sold Shares Held Valued At
Susquehanna International Sep 2025 17k $72k
Sabby Management Sep 2025 8.7k $37k
GPS Wealth Strategies Group Sep 2025 1.2k $5.3k
Advisory Services Network Sep 2025 59.00 $252.997900
Sontag Advisory Sep 2025 15.00 $64.999500